Clinical Trial Update: Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects [Phase 2]

View source ↗

Summary

Phase 2 trial update reporting multiple-dose pharmacokinetics of depot buprenorphine in opioid-dependent subjects; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid-related Disorders

Drugs mentioned

• Depot buprenorphine (buprenorphine)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Related Disorder | Phase 2 | Status: COMPLETED | Results posted: 2018-01-23